Amerise Biosciences Ltd
AMERISEAmerise Biosciences Ltd
AMERISE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -64.04 | 1.55 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 29.42 | 3.34 | 1.39% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Amerise Biosciences Ltd is currently inactive and did not generate any revenue.
Peers
Compare with peersCentury Plyboards (India) Ltd
Greenpanel Industries Ltd
Greenply Industries Ltd
Indian Wood Products Co Ltd
Archidply Industries Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 1.18 | 0.00 | — | 9.58 | 0.01 | 0.04 | 0.04 | ||||||||||
Raw Materials | — | — | — | — | — | — | — | — | — | 0.17 | ||||||||||
| Power & Fuel Cost | — | — | — | — | — | — | — | — | — | |||||||||||
| Employee Cost | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 | 0.05 | 0.02 | 0.07 | |||||||||||
| Selling & Administrative Expenses | — | — | — | — | — | — | — | — | — | |||||||||||
| Operating & Other expenses | 0.02 | 0.93 | 0.01 | 1.16 | 0.11 | 0.13 | 8.97 | 0.11 | 0.11 | |||||||||||
EBITDA | -0.03 | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | -0.13 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | -0.03 | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | -0.13 | ||||||||||
| Interest & Other Items | — | — | — | — | — | — | — | — | — | — | ||||||||||
| PBT | -0.03 | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | -0.13 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -0.03 | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | -0.13 | ||||||||||
| EPS | -0.00 | -0.14 | -0.00 | 0.00 | -0.02 | -0.03 | 0.08 | -0.02 | -0.02 | -0.02 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
MaterialsWood Products
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Amerise Biosciences Ltd | -59.46 | 1.55 | — |
| Century Plyboards (India) Ltd | 51.50 | 7.62 | 0.13% |
| Greenpanel Industries Ltd | 29.92 | 3.24 | 0.43% |
| Greenply Industries Ltd | 55.89 | 5.51 | 0.16% |
Price Comparison
Compare AMERISE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
AMERISE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet Loss of Amerise Biosciences reported to Rs 0.03 crore in the quarter ended September 2024 as against net loss of Rs 0.04 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 22 October 2024.Powered by Capital Market - Live
Amerise Biosciences announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net Loss of Amerise Biosciences reported to Rs 0.05 crore in the quarter ended June 2024 as against net loss of Rs 0.07 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
Amradeep Industries renames as ‘Amerise Biosciences’
Amradeep Industries reports standalone net profit of Rs 0.30 crore in the June 2021 quarter
Amradeep Industries reports standalone net loss of Rs 0.30 crore in the March 2021 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -49.18%, vs industry avg of 11.16%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.02% to 0%